Wellington Management Group LLP Regenxbio Inc. Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.51 - $21.53 $66,792 - $124,938	5,803 Added 21.61%	32,652 $382,000
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $326,752 - $660,753	26,849 New	26,849 $565,000
Q4 2023 Feb 12, 2024	BUY	$12.89 - $20.82 $496,716 - $802,298	38,535 New	38,535 $691,000
Q4 2020 Feb 12, 2021	SELL	$26.52 - $49.35 $251,621 - $468,232	-9,488 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $8.17 Million - $12.2 Million	-302,318 Reduced 96.96%	9,488 $261,000
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $2.84 Million - $4.45 Million	-102,473 Reduced 24.74%	311,806 $11.5 Million
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $504,992 - $1.27 Million	-23,488 Reduced 5.37%	414,279 $13.4 Million
Q4 2019 Feb 11, 2020	BUY	$34.54 - $44.87 $15.1 Million - $19.6 Million	437,767 New	437,767 $17.9 Million

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.